bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 29, 2024
Abstract
Epidemiological
studies
reveal
that
a
diagnosis
of
inflammatory
bowel
disease
(IBD)
is
associated
with
an
increased
risk
developing
Parkinson’s
(PD).
The
presence
gut
dysbiosis
has
been
documented
in
both
PD
and
IBD
patients,
however
it
currently
unknown
how
alterations
the
microbiome
may
contribute
to
epidemiological
link
between
diseases.
To
identify
shared
distinct
features
microbiome,
we
performed
first
joint
analysis
54
PD,
26
IBD,
16
healthy
control
metagenomes
recruited
from
clinics
at
University
Florida,
directly
compared
microbiomes
persons.
Larger,
publicly
available
metagenomic
datasets
were
also
analyzed
validate
extend
our
findings.
Depletions
short-chain
fatty
acid
(SCFA)
producing
bacteria,
including
Roseburia
intestinalis,
Faecalibacterium
prausnitzii,
Anaerostipes
hadrus,
Eubacterium
rectale
,
as
well
depletions
SCFA
synthesis
pathways,
demonstrated
across
datasets.
We
posit
direct
comparison
will
be
important
identifying
within
which
PD.
data
revealed
consistent
depletion
SCFA-producing
bacteria
suggesting
loss
these
microbes
influence
pathophysiology
states.
PeerJ,
Journal Year:
2023,
Volume and Issue:
11, P. e15777 - e15777
Published: Aug. 4, 2023
Colorectal
cancer
(CRC),
which
develops
from
the
gradual
evolution
of
tubular
adenomas
and
serrated
polyps
in
colon
rectum,
has
a
poor
prognosis
high
mortality
rate.
In
addition
to
genetics,
lifestyle,
chronic
diseases,
intestinal
integrity
microbiota
(which
facilitate
digestion,
metabolism,
immune
regulation)
could
promote
CRC
development.
For
example,
enterotoxigenic
Bacteroides
fragilis
,
genotoxic
Escherichia
coli
(pks+
E.
coli)
Fusobacterium
nucleatum
members
microbiota,
are
highly
correlated
CRC.
This
review
describes
roles
mechanisms
these
three
bacteria
Their
interaction
during
initiation
progression
also
been
proposed.
Our
view
is
that
precancerous
stage
colorectal
cancer,
ETBF
causes
inflammation,
leading
potential
changes
ecology
may
provide
basic
conditions
for
pks+
colonization
induction
oncogenic
mutations,
when
cancerous
epithelial
cells
can
further
recruit
F.
colonise
lesion
site
contribute
advancement
by
primarily
development
cells,
stemization,
proliferation,
create
new
tailored
preventive,
screening
therapeutic
interventions.
However,
there
most
dominant
each
development,
not
neglecting
possibility
two
or
even
all
be
engaged
at
any
disease.
The
relationship
between
associated
gut
important
information
strategies
assess
use
studies,
antibiotic
therapy,
prevention
strategies.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(23), P. 4993 - 4993
Published: Dec. 1, 2023
Inflammatory
bowel
disease
(IBD)
is
a
chronic
associated
with
overactive
inflammation
and
gut
dysbiosis.
Owing
to
the
beneficial
effects
of
bifidobacteria
on
IBD
treatment,
this
study
aimed
investigate
anti-inflammation
an
exopolysaccharide
(EPS)-producing
strain
Bifidobacterium
pseudocatenulatum
Bi-OTA128
through
dextran
sulfate
sodium
(DSS)-induced
colitis
mice
model.
B.
treatment
improved
DSS-induced
symptoms
maintained
intestinal
barrier
integrity
by
up-regulating
MUC2
tight
junctions’
expression.
The
oxidative
stress
was
reduced
after
increasing
antioxidant
enzymes
SOD,
CAT,
GSH-Px
in
colon
tissues.
Moreover,
inflammatory
responses
were
also
inhibited
decreasing
pro-inflammatory
cytokines
TNF-α,
IL-1β,
IL-6,
but
anti-inflammatory
cytokine
IL-10.
EPS-producing
showed
better
than
that
non-EPS-producing
stain
BLYR01-7
modulating
increased
relative
abundance
bacteria
decreased
maleficent
Escherichia-Shigella,
Enterorhabuds,
Enterobacter,
Osillibacter
inflammation.
Notably,
genera
Clostridium
sensu
stricto
only
enriched
Bi-OTA128-treated
mice,
which
could
degrade
polysaccharides
produce
acetic
acid
butyrate
gut.
This
finding
demonstrated
cross-feeding
effect
induced
microbiota.
Collectively,
these
results
highlighted
colitis,
be
used
as
candidate
probiotic
supporting
recovery
from
ongoing
colitis.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 29, 2024
Abstract
Epidemiological
studies
reveal
that
a
diagnosis
of
inflammatory
bowel
disease
(IBD)
is
associated
with
an
increased
risk
developing
Parkinson’s
(PD).
The
presence
gut
dysbiosis
has
been
documented
in
both
PD
and
IBD
patients,
however
it
currently
unknown
how
alterations
the
microbiome
may
contribute
to
epidemiological
link
between
diseases.
To
identify
shared
distinct
features
microbiome,
we
performed
first
joint
analysis
54
PD,
26
IBD,
16
healthy
control
metagenomes
recruited
from
clinics
at
University
Florida,
directly
compared
microbiomes
persons.
Larger,
publicly
available
metagenomic
datasets
were
also
analyzed
validate
extend
our
findings.
Depletions
short-chain
fatty
acid
(SCFA)
producing
bacteria,
including
Roseburia
intestinalis,
Faecalibacterium
prausnitzii,
Anaerostipes
hadrus,
Eubacterium
rectale
,
as
well
depletions
SCFA
synthesis
pathways,
demonstrated
across
datasets.
We
posit
direct
comparison
will
be
important
identifying
within
which
PD.
data
revealed
consistent
depletion
SCFA-producing
bacteria
suggesting
loss
these
microbes
influence
pathophysiology
states.